By Sabela OjeaThe Oncology Institute is buying back 2 million shares of its common stock, the company said in a Securities and Exchange Commission filing Wednesday. Its board of directors approved the share-repurchase program Monday. The institute didn't provide details on what motivated it to repurchase the stock. Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix(END) Dow Jones NewswiresAugust 30, 2023 16:11 ET (20:11 GMT)Copyright (c) 2023 Dow Jones & Company, Inc.

Source: Wall Street Journal August 31, 2023 02:22 UTC